Jeff Yass’s Coya Therapeutics COYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$321K Buy
64,144
+3,138
+5% +$15K ﹤0.01% 10807
2026
Q2
$357K Buy
61,006
+21,690
+55% +$100K ﹤0.01% 10668
2026
Q1
$155K Sell
39,316
-85,515
-69% -$400K ﹤0.01% 11963
2025
Q4
$724K Buy
124,831
+91,476
+274% +$556K ﹤0.01% 7949
2025
Q3
$190K Sell
33,355
-16,795
-33% -$102K ﹤0.01% 11048
2025
Q2
$288K Sell
50,150
-8,832
-15% -$51.2K ﹤0.01% 10430
2025
Q1
$382K Buy
58,982
+28,247
+92% +$179K ﹤0.01% 9513
2024
Q4
$176K Buy
+30,735
New +$209K ﹤0.01% 10865

Other funds holding COYA

Jeff Yass's COYA Position: Q3 2026 in Review

Jeff Yass increased its Coya Therapeutics (COYA) stake by 5.1% in Q3 2026, buying an estimated $15K and bringing the position to 64,144 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #10807.

Jeff Yass first reported a position in COYA in Q4 2024 and has held it in 8 quarters since. The position peaked at $724K in Q4 2025. 52 funds tracked by Wall St. Rank hold COYA as of Q3 2026.

  • Jeff Yass held 64,144 shares of Coya Therapeutics worth $321K as of Q3 2026.
  • Jeff Yass bought 3,138 Coya Therapeutics shares in Q3 2026, an estimated $15K.
  • Coya Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10807 holding.
  • Jeff Yass first reported a position in Coya Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • Jeff Yass's Coya Therapeutics position peaked at $724K in Q4 2025.
  • 52 funds tracked by Wall St. Rank held Coya Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.